Viridian Therapeutics, Inc.
VRDN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001590750
In the last 90 days, Viridian Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 214 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Viridian Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 122
- +18 vs. Q3 2022
- Shares held
- 41.2M
- +3.30M (+8.7%) vs. Q3 2022
- Total value
- $1.21B
- +$428.1M (+55.0%) vs. Q3 2022
- New holders
- 30
- 52 more added
- Sold out
- 12
- 29 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VRDN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 214 | $2.50B |
| Q1 2026 | 225 | $2.21B |
| Q4 2025 | 229 | $3.36B |
| Q3 2025 | 169 | $2.01B |
| Q2 2025 | 171 | $1.32B |
| Q1 2025 | 177 | $1.23B |
| Q4 2024 | 179 | $1.75B |
| Q3 2024 | 165 | $1.98B |
| Q2 2024 | 138 | $906.2M |
| Q1 2024 | 136 | $1.24B |
| Q4 2023 | 132 | $1.31B |
| Q3 2023 | 124 | $769.9M |
| Q2 2023 | 128 | $1.12B |
| Q1 2023 | 135 | $1.10B |
| Q4 2022 | 122 | $1.21B |
| Q3 2022 | 105 | $778.5M |
| Q2 2022 | 84 | $327.7M |
| Q1 2022 | 72 | $460.9M |
| Q4 2021 | 55 | $459.8M |
| Q3 2021 | 39 | $223.7M |
| Q2 2021 | 26 | $109.8M |
| Q1 2021 | 33 | $84.5M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Viridian Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 710,985 | $20.8M | 0.00% | +111,219+18.5% | Added |
| Millennium Management LLC | 785,854 | $23.0M | 0.03% | +23,794+3.1% | Added |
| Octagon Capital Advisors LP | 824,200 | $24.1M | 3.75% | +824,200 | New |
| Ra Capital Management, L.P. | 880,000 | $25.7M | 0.52% | 00.0% | Unchanged |
| Alliancebernstein L.P. | 923,833 | $27.0M | 0.01% | +923,833 | New |
| Yiheng Capital Management, L.P. | 963,256 | $28.1M | 2.18% | +590,205+158.2% | Added |
| TCG Crossover Management, LLC | 983,610 | $28.7M | 5.07% | −180,390−15.5% | Reduced |
| Logos Global Management LP | 1,000,000 | $29.2M | 3.42% | 00.0% | Unchanged |
| Kynam Capital Management, LP | 1,034,697 | $30.2M | 4.64% | +34,697+3.5% | Added |
| Cormorant Asset Management, LP | 1,100,000 | $32.1M | 2.16% | −210,000−16.0% | Reduced |
| Citadel Advisors LLC | 1,202,318 | $35.1M | 0.04% | −158,294−11.6% | Reduced |
| Perceptive Advisors LLC | 1,220,575 | $35.7M | 1.03% | 00.0% | Unchanged |
| BVF Inc | 1,238,974 | $36.2M | 1.53% | −502,866−28.9% | Reduced |
| Fairmount Funds Management LLC | 1,369,623 | $40.0M | 6.35% | 00.0% | Unchanged |
| Vivo Capital, LLC | 1,678,207 | $49.0M | 5.94% | +18,188+1.1% | Added |
| Paradigm Biocapital Advisors LP | 1,751,167 | $51.2M | 6.00% | +114,956+7.0% | Added |
| Deep Track Capital, LP | 1,771,154 | $51.7M | 2.26% | −199,136−10.1% | Reduced |
| State Street Corp | 1,863,190 | $54.4M | 0.00% | +684,641+58.1% | Added |
| Commodore Capital LP | 2,020,166 | $59.0M | 8.89% | −676,174−25.1% | Reduced |
| Vanguard Group Inc | 2,114,994 | $61.8M | 0.00% | +258,194+13.9% | Added |
| VR Adviser, LLC | 2,699,865 | $78.9M | 13.29% | +569,557+26.7% | Added |
| BlackRock Inc. | 2,761,556 | $80.7M | 0.00% | +779,494+39.3% | Added |
| Eversept Partners, LP | 0 | $0 | 0.00% | −478,387−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −101,600−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −81,870−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −35,445−100.0% | Sold out |
| Parkman Healthcare Partners LLC | 0 | $0 | 0.00% | −35,358−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −27,118−100.0% | Sold out |
| Seven Grand Managers, LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −20,848−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −19,518−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −15,764−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −808−100.0% | Sold out |
| GPS Wealth Strategies Group, LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Jefferies Group LLC | – | – | – | – | Not filed |